This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Saxena, A. Articles by Gnanasekaran, N. Search for Related Content PubMed PubMed Citation Articles by Saxena, A. Articles by Gnanasekaran, N. Social Bookmarking                         What's this?

Comparison of piroxicam and acetylsalicylic acid for pain in head and neck cancers: a double-blind study

Department of Anaesthesiology All India Institute of Medical Sciences

Manoj Andley

Department of Anaesthesiology All India Institute of Medical Sciences

N. Gnanasekaran

Computer Center Facility, All India Institute of Medical Sciences, Ansari Nagar, New-Delhi

This double-blind, placebo controlled study compared the analgesic efficacy of piroxicam with acetylsalicylic acid (ASA) in patients having continuous pain with advanced head and neck cancers. They were randomly divided into two groups of 25 patients each; 36 of these 50 patients completed the study. After four days of treatment, there was a significant reduction in a modified numerical rating scale (NRS) of pain in the piroxicam group as well as in the ASA group. There was a concomitant increase in the hours of sleep in the piroxicam group and in the ASA group. The decrease in NRS and the increase in sleeping hours was not statistically significantly different between the two groups. Patients receiving piroxicam had a low incidence of upper gastrointestinal side-effects compared with those receiving ASA. The results of this study suggest that piroxicam can be used as first line treatment in place of ASA in patients with head and neck cancers suffering from moderate to severe pain. The advantages are less frequent dosing, better patient compliance and few side-effects.

Key Words: anti-inflammatory agents • non-steroidal • aspirin • head and neck neoplasms • pain • palliative treatment • piroxicam

Palliative Medicine, Vol. 8, No. 3, 223-229 (1994)
DOI: 10.1177/026921639400800306


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?